PODD · Insulet Corp
Snapshot
50 fields · last close| Market Cap | $9.58B |
| P/E | 26.01 |
| Float | 69.02M |
| Beta | 1.09 |
| Volatility | 27.2% |
| Exchange | NASDAQ |
| Sector | Health Care |
| Cap tier | Mid cap |
| Macro sensitivity | Moderate |
| Clavix score | 68.6 |
| Price | 136.31 |
| Change | −1.32% |
| Prev Close | 138.13 |
| Open | 140.79 |
| Day Low | 137.12 |
| Day High | 141.86 |
| Avg Vol | 2 |
| Avg $ Vol | $242.3M |
| 52W High | 354.88 |
| 52W Low | 126.40 |
| 52W Pos | 4.3% |
| From High | −61.59% |
| From Low | +7.84% |
| Max DD 1Y | — |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | — |
| SMA 50 | — |
| SMA 200 | — |
| RSI (14) | — |
| Vol 30D | — |
| Vol 90D | — |
| 1Y Range | 126–355 |
| Daily bars | — |
| Perf Week | — |
| Perf Month | — |
| Perf Quarter | — |
| Perf Half Y | — |
| Perf Year | — |
| Perf YTD | — |
| Prev Day | −1.32% |
| Clavix | B- |
| Debt / Eq | 0.93 |
| Curr Ratio | 2.81 |
| Int Cover | 14.7× |
| FCF Margin | 14.0% |
| Rev Growth | +30.7% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 43 / 49 |
What PODD does
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.
The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System.
It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy.
The company sells its products to end-users through the pharmacy channel; and independent distributors.
Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Clavix risk grade
regraded every trading dayPODD grades B-, 68.6 of 100. Steadiest on News Sentiment (67), most exposed on Price Stability (50, mixed). 1 of the 4 weighted dimensions sit above the Health Care median. Ranks 43 of 49 in Health Care by Clavix score.
How rough the ride is
| PODD | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 1.09 | 0.85 |
| Volatilityannualized | 27.2% | 21.3% |
| Max drawdown, past yearworst peak-to-trough fall | — | — |
| Typical daily movemedian absolute daily change | — | — |
| Days beyond ±3%of the last 0 sessions | — | — |
Market sensitivity
| PODD | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 1.09 | 0.85 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate 53% of 49 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| PODD | |
|---|---|
| 1 week | — |
| 1 month | — |
| Year to date | — |
| 1 year | — |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| PODD | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 28 Aug |
| Average score0 most bearish, 100 most bullish | 40 |
| Bullish · bearisharticles above 60 · below 40 | 6 · 16 |
| Directionarticles whose tone is improving vs worsening | 6 ↑ 16 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.
Growth
| PODD | |
|---|---|
| Revenue growthyear over year | +30.7% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openInsulet (PODD) announced the full U.S. market release of Omnipod Discover, a web-based platform that turns diabetes data from its Omnipod 5 insulin pump into charts and personalized insights for patients, caregivers, and healthcare providers.
Wall Street Zen upgraded Insulet from a "hold" rating to a "buy" rating in a research note issued on Saturday. No further details or reasons were provided.
The article body is truncated and provides no further details.
Insulet COO Eric Benjamin said the company is focused on expanding adoption of its automated insulin delivery systems (devices that automatically adjust insulin based on glucose readings) in large, underpenetrated diabetes markets, while working to reduce higher-than-expected early customer drop-off among some Type 2 diabetes users.
Insulet's COO Eric Benjamin said the company is focused on growing adoption of its automated insulin delivery (AID) systems, which automatically adjust insulin doses based on glucose readings, in large and underpenetrated diabetes markets. He also highlighted the need to address higher-than-expected early dropout among some Type 2 diabetes customers, as the Omnipod 6 and international expansion gain traction.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| HSIC | Henry Schein Inc | A- | $9.48B | 23.32 | 0.86 | Compare |
| GKOS | Glaukos Corp | B | $9.76B | — | 0.73 | Compare |
| ALGN | Align Technology Inc | B | $10.20B | 24.43 | 1.74 | Compare |
| GMED | Globus Medical Inc | B | $10.25B | 19.12 | 0.97 | Compare |
| COO | Cooper Companies Inc | B- | $10.38B | 18.55 | 0.83 | Compare |
| UHS | Universal Health Services Inc | A- | $10.55B | 6.87 | 1.12 | Compare |
| HNGE | Hinge Health Inc | C+ | $8.48B | 77.79 | 1.51 | Compare |
| MOH | Molina Healthcare Inc | B | $10.94B | 23.74 | 0.74 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.